Showing results (1-10 of 19) with videos related to
Sort By:
Pageof 2
Journal of Geriatric Cardiology : JGC|January 24, 2013
High density lipoproteins and atherosclerosis: emerging aspectsFederica Sala, Alberico Luigi Catapano, Giuseppe Danilo NorataAtherosclerosis|December 25, 2012
MicroRNAs and lipoproteins: a connection beyond atherosclerosis?Giuseppe Danilo Norata, Federica Sala, Alberico Luigi Catapano, et al.Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|December 10, 2013
Development and validation of two liquid chromatography-tandem mass spectrometry methods for the determination of silibinin and silibinin hemisuccinate in human plasmaFederica Sala, Pablo Albares, Milena Colovic, et al.Journal of Mass Spectrometry : JMS|October 18, 2007
Simultaneous determination of gemcitabine and its main metabolite, dFdU, in plasma of patients with advanced non-small-cell lung cancer by high-performance liquid chromatography-tandem mass spectrometryElena Marangon, Federica Sala, Orazio Caffo, et al.Journal of Mass Spectrometry : JMS|October 21, 2011
Development and validation of a high-performance liquid chromatography-tandem mass spectrometry method for the determination of the novel inhibitor of angiogenesis E-3810 in human plasma and its application in a clinical pharmacokinetic studyFederica Sala, Renzo Bagnati, Valeria Livi, et al.Pharmacology Research & Perspectives|February 7, 2025
Phase I Study of the Safety, Tolerability, and Pharmacokinetics of Inhaled Voriconazole in Healthy Volunteers and Subjects With Stable AsthmaGiovanni Caponetti, Federica Sala, Antonio Cervetti, et al.Journal of Mass Spectrometry : JMS|September 28, 2010
Development and validation of a high-performance liquid chromatography-tandem mass spectrometry method for the determination of the novel proteasome inhibitor CEP-18770 in human plasma and its application in a clinical pharmacokinetic studyFederica Sala, Elena Marangon, Renzo Bagnati, et al.Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|August 22, 2009
Development and validation of a liquid chromatography-tandem mass spectrometry method for the determination of ST1926, a novel oral antitumor agent, adamantyl retinoid derivative, in plasma of patients in a Phase I studyFederica Sala, Massimo Zucchetti, Renzo Bagnati, et al.Drug Metabolism and Drug Interactions|April 25, 2013
Silibinin hemisuccinate binding to proteins in plasma and blood cell/plasma partitioning in mouse, rat, dog and man in vitroStefano Persiani, Federica Sala, Richard Cole, et al.Journal of Pharmaceutical and Biomedical Analysis|March 26, 2014
Quantification of trabectedin in human plasma: validation of a high-performance liquid chromatography-mass spectrometry method and its application in a clinical pharmacokinetic studyMonique Zangarini, Laura Ceriani, Federica Sala, et al.Pageof 2